Evidence map›Paper›PMID 36185155›Full record

ArticleHeliyon2022

A probiotic blend improves defecation, mental health, and productivity in healthy Japanese volunteers under stressful situations.

Takumi Sato, Shinichi Honda, Yuji Tominaga, Yo Miyakoshi, Takahiro Ueda, Jinko Sawashita

Abstract read
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Synbiotic combination ofGut microbes reports · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Takumi SatoProbiotics Project Team, Supplement Strategic Unit, Pharma & Supplemental Nutrition Solutions Vehicle, Kaneka Corporation, 1-12-32 Akasaka, Minato-ku, Tokyo 107-6028, Japan.
Shinichi HondaBioproducts Research Group, Biotechnology Research Laboratories, Pharma & Supplemental Nutrition Solutions Vehicle, Kaneka Corporation, 1-8 Miyamae-cho, Takasago-cho, Takasago-shi, Hyogo 676-8688, Japan.
Yuji TominagaBioproducts Research Group, Biotechnology Research Laboratories, Pharma & Supplemental Nutrition Solutions Vehicle, Kaneka Corporation, 1-8 Miyamae-cho, Takasago-cho, Takasago-shi, Hyogo 676-8688, Japan.
Yo MiyakoshiProbiotics Project Team, Supplement Strategic Unit, Pharma & Supplemental Nutrition Solutions Vehicle, Kaneka Corporation, 1-12-32 Akasaka, Minato-ku, Tokyo 107-6028, Japan.
Takahiro UedaProbiotics Project Team, Supplement Strategic Unit, Pharma & Supplemental Nutrition Solutions Vehicle, Kaneka Corporation, 1-12-32 Akasaka, Minato-ku, Tokyo 107-6028, Japan.
Jinko SawashitaProducts Technology Team, Supplement Strategic Unit, Pharma & Supplemental Nutrition Solutions Vehicle, Kaneka Corporation, 2-3-18 Nakanoshima, Kita-ku, Osaka 530-8288, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated whether a blend of probiotics (KABP-021, KABP-022, and KABP-023) improved diarrhea-related problems in healthy Japanese adults who routinely lived under stressful conditions. Twenty-six females and 34 males were divided randomly into the probiotic and placebo groups in this double-blind, placebo-controlled, parallel-group comparison study. All participants ingested 1 capsule of probiotics or placebo per day for 4 weeks. Intervention with probiotics significantly reduced diarrhea-related problems assessed by the Izumo scale compared with placebo treatment (

Indexed as

AbsenteeismDiarrheaHealthy volunteersIrritable bowel syndromeMental healthPresenteeismProbiotic

Identifiers

PMID36185155
PMCPMC9520207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.